semaglutide bimagrumab Obesity research is moving beyond how much weight we lose to what kind of weight we lose Combination bimagrumab plus semaglutide confers

If you experience severe nausea, persistent vomiting, significant fatigue, or difficulty staying hydrated during non-fasting hours, it may be advisable to pause your treatment for the month of Ramadan

Hormonal IUDs also offer additional benefits, such as lighter periods or even no periods at all, while copper IUDs offer a hormone-free option

The next FDA review is July 23, 2026, so keep an eye out for updates

GLP-1s have a low risk of causing hypoglycemia

Cut to the chase: A review of CD26/dipeptidyl peptidase-4s (DPP4) entanglement in the immune system

The obesity markets next battlefield may not be injection vs injection but injection vs pill